5-HT receptors and reward-related behaviour: A review

Neuroscience and Biobehavioral Reviews

Volumn 35, Issue 6, 2011, Pages 1419-1449

  Hayes, Dave J ^a,b   Greenshaw, Andrew J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL OTTAWA HEALTH CARE GROUP   (Canada)

Author keywords

5 HT; Animal; Behavioural models; Drug self administration; Human; Intracranial self stimulation; Place conditioning; Receptors; Reward; Serotonin

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; 8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; 8,9 DICHLORO 2,3,4,4A TETRAHYDRO 1H PYRAZINO[1,2 A]QUINOXALIN 5(6H) ONE; AZASETRON; BUSPIRONE; GEPIRONE; GRANISETRON; IPSAPIRONE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; ONDANSETRON; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; UNINDEXED DRUG; VOLINANSERIN;

ANIMAL BEHAVIOR; COGNITION; CONDITIONING; DEPRESSION; DOSE RESPONSE; DRUG DEPENDENCE; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SELF ADMINISTRATION; HUMAN; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REINFORCEMENT; REVIEW; REWARD; SELF STIMULATION; SEROTONINERGIC SYSTEM; SUBSTANCE ABUSE;

ANIMALS; BRAIN; HUMANS; RECEPTORS, SEROTONIN; REWARD; SEROTONIN;

EID: 79954589565     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2011.03.005     Document Type: Review

References (267)

1. 3 antagonists. Psychopharmacology (Berl.) 1990, 100:459-463.
2. Ahn K.C., Pazderka-Robinson H., Clements R., Ashcroft R., Ali T., Morse C., Greenshaw A.J. Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA self-stimulation thresholds in rats. Psychopharmacology (Berl.) 2005, 178:381-388.
3. Akimova E., Lanzenberger R., Kasper S. The serotonin-1A receptor in anxiety disorders. Biol. Psychiatry 2009, 66:627-635.
4. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 2007, 113:296-320.
5. Ali I., Kelly M.E. Buspirone fails to affect cocaine-induced conditioned place preference in the mouse. Pharmacol. Biochem. Behav. 1997, 58:311-315.
6. 2C receptors. Pharmacol. Ther. 2009, 121:160-173.
7. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J. Comp. Neurol. 1978, 179:641-667.
8. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999, 38:1083-1152.
9. Barot S.K., Ferguson S.M., Neumaier J.F. 5-HT(1B) receptors in nucleus accumbens efferents enhance both rewarding and aversive effects of cocaine. Eur. J. Neurosci. 2007, 25:3125-3131.
10. 3 antagonists fail to affect ethanol self-administration of rats. Alcohol 1994, 11:389-395.
11. 2a receptors reduces haloperidol-induced attenuation of reward. Neuropsychopharmacology 2007, 32:551-561.
12. Berg K.A., Clarke W.P., Cunningham K.A., Spampinato U. Fine-tuning serotonin(2c) receptor function in the bra molecular functional implications. Neuropharmacology 2008.
13. 2C receptors for the treatment of depression. Prog. Brain Res. 2008, 172:287-305.
14. Berridge K.C., Robinson T.E. Parsing reward. Trends Neurosci. 2003, 26:507-513.
15. Berridge K.C., Robinson T.E., Aldridge J.W. Dissecting components of reward: 'liking' 'wanting', and learning. Curr. Opin. Pharmacol. 2009, 9:65-73.
16. Bhagwagar Z., Hinz R., Taylor M., Fancy S., Cowen P., Grasby P. Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907. Am. J. Psychiatry 2006, 163:1580-1587.
17. 3 receptor antagonist, tropisetron, does not influence ethanol-induced conditioned taste aversion and conditioned place aversion. Alcohol 1997, 14:63-69.
18. 3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 1991, 39:509-512.
19. 1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro. Brain Res. 1996, 721:59-65.
20. Bonaventure P., Kelly L., Aluisio L., Shelton J., Lord B., Galici R., Miller K., Atack J., Lovenberg T.W., Dugovic C. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 2007, 321:690-698.
21. 1D receptor mRNA in serotonergic cell bodies in guinea pig dorsal raphe nucleus: a double labeling in situ hybridization histochemistry study. Neurosci. Lett. 1998, 254:113-116.
22. 2C receptors. Br. J. Pharmacol. 1995, 115:622-628.
23. Borisenko S.A., Meng Q.H., Rauhala P., Mannisto P.T. Neurochemical mediators of anxiety have inconsistent effects on hypothalamic self-stimulation in rats. Pharmacol. Toxicol. 1996, 78:354-360.
24. Boulton A.A., Baker G.B., Wu P.H. Animal Models of Drug Addiction, Neuromethods 1993, Springer, New York, p. 460.
25. Braida D., Iosue S., Pegorini S., Sala M. 3,4 methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system. Pharmacol. Res. 2005, 51:177-182.
26. Broadbent J., Greenshaw A.J. Effects of quipazine and of tryptamine on self-stimulation of median raphe nucleus and of lateral hypothalamus in rats. Pharmacol. Biochem. Behav. 1985, 23:943-947.
27. 1B binding sites in rat brain. Naunyn Schmiedebergs Arch. Pharmacol. 1993, 347:569-582.
28. 2C receptors in the ventral tegmental area. Neuroscience 2007, 146:286-297.
29. Budygin E.A., Brodie M.S., Sotnikova T.D., Mateo Y., John C.E., Cyr M., Gainetdinov R.R., Jones S.R. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7781-7786.
30. Butini S., Budriesi R., Hamon M., Morelli E., Gemma S., Brindisi M., Borrelli G., Novellino E., Fiorini I., Ioan P., Chiarini A., Cagnotto A., Mennini T., Fracasso C., Caccia S., Campiani G. Novel, potent, and selective quinoxaline-based 5-HT(3) receptor ligands. 1. Further structure-activity relationships and pharmacological characterization. J. Med. Chem. 2009, 52:6946-6950.
31. Campbell A.D., Kohl R.R., McBride W.J. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol 1996, 13:569-574.
32. 3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes. Eur. J. Pharmacol. 1995, 290:157-162.
33. 3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology (Berl.) 1989, 97:175-178.
34. 3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur. J. Pharmacol. 1988, 151:159-160.
35. Carlezon W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat. Protoc. 2007, 2:2987-2995.
36. 1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin. Brain Res. 1995, 704:153-166.
37. 1B receptors: a comparison of knockouts and antagonists. Pharmacol. Biochem. Behav. 2000, 67:559-566.
38. 3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats. Pharmacol. Biochem. Behav. 1996, 55:33-37.
39. Cervo L., Rozio M., Ekalle-Soppo C.B., Carnovali F., Santangelo E., Samanin R. Stimulation of serotonin1B receptors induces conditioned place aversion and facilitates cocaine place conditioning in rats. Psychopharmacology (Berl.) 2002, 163:142-150.
40. Chanrion B., Mannoury la Cour C., Gavarini S., Seimandi M., Vincent L., Pujol J.F., Bockaert J., Marin P., Millan M.J. Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol. Pharmacol. 2008, 73:748-757.
41. 3 receptors in Fawn-Hooded rats: a quantitative autoradiography study. Alcohol Clin. Exp. Res. 2000, 24:1093-1102.
42. 1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide. J. Med. Chem. 2008, 51:3609-3616.
43. 3 receptors in P and in AA alcohol-preferring rats: an autoradiographic study. Brain Res. Bull. 1998, 46:311-315.
44. Cifariello A., Pompili A., Gasbarri A. 5-HT(7) receptors in the modulation of cognitive processes. Behav. Brain Res. 2008, 195:171-179.
45. Ciranna L. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Curr. Neuropharmacol. 2006, 4:101-114.
46. 2C receptor protein in the rat CNS. Neuropharmacology 2000, 39:123-132.
47. Colpaert F.C., Deseure K., Stinus L., Adriaensen H. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J. Pharmacol. Exp. Ther. 2006, 316:892-899.
48. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12:31-40.
49. 3 antagonists ICS 205-930 and MDL 72222. Pharmacol. Biochem. Behav. 1994, 49:67-71.
50. 3 receptors. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:27-37.
51. 1B serotonin receptors. Nat. Genet. 1996, 14:98-101.
52. Crockett M.J., Clark L., Robbins T.W. Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J. Neurosci. 2009, 29:11993-11999.
53. Czoty P.W., McCabe C., Nader M.A. Effects of the 5-HT(1A) agonist (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on cocaine choice in cynomolgus monkeys. Behav. Pharmacol. 2005, 16:187-191.
54. Dahlstrom A., Fuxe K. Localization of monoamines in the lower brain stem. Experientia 1964, 20:398-399.
55. Daubert E.A., Condron B.G. Serotonin: a regulator of neuronal morphology and circuitry. Trends Neurosci. 2010, 33:424-434.
56. David V., Segu L., Buhot M.C., Ichaye M., Cazala P. Rewarding effects elicited by cocaine microinjections into the ventral tegmental area of C57BL/6 mice: involvement of dopamine D1 and serotonin1B receptors. Psychopharmacology (Berl.) 2004, 174:367-375.
57. Davidson C., Lazarus C., Lee T.H., Ellinwood E.H. Ondansetron, given during the acute cocaine withdrawal, attenuates oral cocaine self-administration. Eur. J. Pharmacol. 2004, 503:99-102.
58. Davidson C., Lee T.H., Xiong Z., Ellinwood E.H. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration. Neuropsychopharmacology 2002, 27:542-553.
59. Dayan P., Huys Q.J. Serotonin in affective control. Annu. Rev. Neurosci. 2009, 32:95-126.
60. De Maeyer J.H., Prins N.H., Schuurkes J.A., Lefebvre R.A. Differential effects of 5-hydroxytryptamine4 receptor agonists at gastric versus cardiac receptors: an operational framework to explain and quantify organ-specific behavior. J. Pharmacol. Exp. Ther. 2006, 317:955-964.
61. Di Giovanni G., Di Matteo V., Di Mascio M., Esposito E. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse 2000, 35:53-61.
62. Di Giovanni G., Di Matteo V., La Grutta V., Esposito E. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 2001, 103:111-116.
63. Di Matteo V., Di Giovanni G., Di Mascio M., Esposito E. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 1999, 38:1195-1205.
64. Ding Z.M., Toalston J.E., Oster S.M., McBride W.J., Rodd Z.A. Involvement of local serotonin-2A but not serotonin-1B receptors in the reinforcing effects of ethanol within the posterior ventral tegmental area of female Wistar rats. Psychopharmacology (Berl.) 2009, 204:381-390.
65. 2B receptors in the reinforcing effects of MDMA in mice. PLoS One 2009, 4:e7952.
66. Dracheva S., Lyddon R., Barley K., Marcus S.M., Hurd Y.L., Byne W.M. Editing of serotonin 2C receptor mRNA in the prefrontal cortex characterizes high-novelty locomotor response behavioral trait. Neuropsychopharmacology 2009, 34:2237-2251.
67. Dremencov E., El Mansari M., Blier P. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area. J. Psychiatry Neurosci. 2009, 34:223-229.
68. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., Mathis C. Serotonin type-1A receptor imaging in depression. Nucl. Med. Biol. 2000, 27:499-507.
69. Duxon M.S., Flanigan T.P., Reavley A.C., Baxter G.S., Blackburn T.P., Fone K.C. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 1997, 76:323-329.
70. Emsley R. Drugs in development for the treatment of schizophrenia. Expert Opin. Invest. Drugs 2009, 18:1103-1118.
71. 1B binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 1986, 332:1-7.
72. 3 receptor over-expression decreases ethanol self administration in transgenic mice. Psychopharmacology (Berl.) 1998, 140:243-248.
73. 3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol. Disord. Drug Targets 2008, 7:454-467.
74. 3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 1991, 26:107-110.
75. Fantegrossi W.E., Ullrich T., Rice K.C., Woods J.H., Winger G. 3 4-Methylenedioxymethamphetamine (MDMA, " ecstasy" ) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl.) 2002, 161:356-364.
76. Fayyaz M., Lackner J.M. Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther. Clin. Risk Manage. 2008, 4:41-48.
77. Feinberg-Zadek P.L., Davies P.A. Ethanol stabilizes the open state of single 5-hydroxytryptamine(3A)(QDA) receptors. J. Pharmacol. Exp. Ther. 2010, 333:896-902.
78. 6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Biol. Psychiatry 2008, 63:207-213.
79. Filip M. Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats. Pharmacol. Rep. 2005, 57:35-46.
80. Fink K.B., Gothert M. 5-HT receptor regulation of neurotransmitter release. Pharmacol. Rev. 2007, 59:360-417.
81. Fiorino F., Severino B., De Angelis F., Perissutti E., Magli E., Frecentese F., Esposito A., Massarelli P., Nencini C., Santagada V., Caliendo G. New 5-HT(1A) receptor ligands containing a N'-cyanoisonicotinamidine nucleus: synthesis and in vitro pharmacological evaluation. Bioorg. Med. Chem. Lett. 2010, 20:2978-2982.
82. Fletcher P.J., Azampanah A., Korth K.M. Activation of 5-HT(1B) receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule. Pharmacol. Biochem. Behav. 2002, 71:717-725.
83. 2C receptor agonist Ro60-0175 into the ventral tegmental area reduces cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 2004, 29:308-318.
84. Fletcher P.J., Grottick A.J., Higgins G.A. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding. Neuropsychopharmacology 2002, 27:576-586.
85. Fletcher P.J., Ming Z.H., Higgins G.A. Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or median raphe nucleus. Psychopharmacology (Berl.) 1993, 113:31-36.
86. Fletcher P.J., Tampakeras M., Sinyard J., Higgins G.A. Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test. Psychopharmacology 2007, 195:223-234.
87. Fletcher P.J., Tampakeras M., Yeomans J.S. Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol. Biochem. Behav. 1995, 52:65-71.
88. Frantz K.J., Hansson K.J., Stouffer D.G., Parsons L.H. 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology 2002, 42:170-180.
89. Furay A.R., Neumaier J.F., Mullenix A.T., Kaiyala K.K., Sandygren N.K., Hoplight B.J. Overexpression of 5-HT(1B) mRNA in nucleus accumbens shell projection neurons differentially affects microarchitecture of initiation and maintenance of ethanol consumption. Alcohol 2010.
90. 6 receptor-like material in the rat central nervous system. Brain Res. 1997, 746:207-219.
91. Geyer M.A. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 1998, 31(Suppl. 2):73-79.
92. Giorgetti M., Tecott L.H. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur. J. Pharmacol. 2004, 488:1-9.
93. 6 receptor ligands with a focus on arylsulfonyltryptamine analogs. Curr. Top. Med. Chem. 2010, 10:579-595.
94. 1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience 2003, 122:491-498.
95. Gold L.H., Balster R.L. Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl.) 1992, 108:289-294.
96. 1B sites. Arch. Int. Pharmacodyn. Ther. 1987, 288:31-42.
97. Green A.R. Neuropharmacology of 5-hydroxytryptamine. Br. J. Pharmacol. 2006, 147(Suppl. 1):S145-S152.
98. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol. Sci. 1993, 14:265-270.
99. Greenshaw A.J. Differential effects of ondansetron, haloperidol and clozapine on electrical self-stimulation of the ventral tegmental area. Behav. Pharmacol. 1993, 4:479-485.
100. Greenshaw A.J., Wishart T.B. Drug action and reward processes. Experimental Psychopharmacology: Concepts and Methods 1987, 233-277. Humana Press, Clifton, New Jersey. A.J.C.T.D. Greenshaw (Ed.).
101. 2 receptor stimulation. Pharmacol. Biochem. Behav. 1997, 58:1045-1049.
102. 1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res. 1997, 745:96-108.
103. Hannon J., Hoyer D. Molecular biology of 5-HT receptors. Behav. Brain Res. 2008, 195:198-213.
104. Harrison A.A., Markou A. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors. J. Pharmacol. Exp. Ther. 2001, 297:316-325.
105. Harrison A.A., Parsons L.H., Koob G.F., Markou A. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist. Psychopharmacology (Berl.) 1999, 141:242-250.
106. 2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. Psychopharmacology (Berl.) 2009, 203:579-588.
107. Hayes D.J., Graham D.A., Greenshaw A.J. Effects of systemic 5-HT(1B) receptor compounds on ventral tegmental area intracranial self-stimulation thresholds in rats. Eur. J. Pharmacol. 2009, 604:74-78.
108. Hayes, D.J., Hoang, J., Greenshaw, A.J., 2010. The role of nucleus accumbens shell GABA receptors on ventral tegmental area intracranial self-stimulation and a potential role for the 5-HT2C receptor. J. Psychopharmacol. [Epub ahead of print], PMID: 21169393.
109. 2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav. Brain Res. 2009, 197:323-330.
110. 7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl.) 2009, 206:345-354.
111. Hensler J.G. Serotonergic modulation of the limbic system. Neurosci. Biobehav. Rev. 2006, 30:203-214.
112. 3 receptor binding and lower baseline plus maze anxiety in the alcohol-preferring inbred fawn-hooded rat. Pharmacol. Biochem. Behav. 2004, 77:281-289.
113. 3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein. Neurosci. Lett. 1992, 140:16-18.
114. 3 receptor antagonists MDL72222 and ondansetron on morphine place conditioning. Psychopharmacology (Berl.) 1992, 106:315-320.
115. Higgins G.A., Joharchi N., Sellers E.M. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J. Pharmacol. Exp. Ther. 1993, 264:1440-1449.
116. Higgins G.A., Wang Y., Sellers E.M. Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats. Pharmacol. Biochem. Behav. 1993, 45:963-966.
117. Hodge C.W., Niehus J.S., Samson H.H. Morphine induced changes in ethanol-and water-intake are attenuated by the 5-HT3/4 antagonist tropisetron (ICS 205-930). Psychopharmacology (Berl.) 1995, 119:186-192.
118. 3 antagonist ICS 205-930. Alcohol 1993, 10:191-196.
119. Hood S.D., Hince D.A., Davies S.J., Argyropoulos S., Robinson H., Potokar J., Nutt D.J. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder. Psychopharmacology (Berl.) 2010, 208:223-232.
120. 1B receptors in rat nucleus accumbens via virally mediated gene transfer increases voluntary alcohol consumption. Alcohol 2006, 38:73-79.
121. 1B mRNA in rat nucleus accumbens shell neurons. Neuropharmacology 2007, 52:444-449.
122. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 2002, 71:533-554.
123. Hu J., Henry S., Gallezot J.D., Ropchan J., Neumaier J.F., Potenza M.N., Sinha R., Krystal J.H., Huang Y., Ding Y.S., Carson R.E., Neumeister A. Serotonin 1B receptor imaging in alcohol dependence. Biol. Psychiatry 2010, 67:800-803.
124. 3 antagonists reduce morphine self-administration in rats. Br. J. Pharmacol. 1993, 110:1341-1346.
125. Ikemoto S. Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci. Biobehav. Rev. 2010, 35:129-150.
126. Ikemoto S., Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res. Brain Res. Rev. 1999, 31:6-41.
127. Ivanova S., Greenshaw A.J. Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron. Psychopharmacology (Berl.) 1997, 134:187-192.
128. Iyer R.N., Bradberry C.W. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization. J. Pharmacol. Exp. Ther. 1996, 277:40-47.
129. Jans L.A., Blokland A. Influence of chronic mild stress on the behavioural effects of acute tryptophan depletion induced by a gelatin-based mixture. Behav. Pharmacol. 2008, 19:706-715.
130. Jans L.A., Korte-Bouws G.A., Korte S.M., Blokland A. The effects of acute tryptophan depletion on affective behaviour and cognition in Brown Norway and Sprague Dawley rats. J. Psychopharmacol. 2010, 24:605-614.
131. 2C receptors suppresses behavioral responses induced by drugs of abuse. Nat. Med. 2006, 12:324-329.
132. Kalueff A.V., Olivier J.D., Nonkes L.J., Homberg J.R. Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci. Biobehav. Rev. 2010, 34:373-386.
133. 3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology (Berl.) 2002, 159:341-350.
134. Katsidoni V., Apazoglou K., Panagis G. Role of serotonin 5-HT(2A) and 5-HT (2C) receptors on brain stimulation reward and the reward-facilitating effect of cocaine. Psychopharmacology (Berl.) 2010.
135. 3 antagonist Y-25130 blocks cocaine-induced lowering of ICSS reward thresholds in the rat. Pharmacol. Biochem. Behav. 2003, 74:297-302.
136. King M.V., Marsden C.A., Fone K.C. A role for the 5-HT(1A), 5-HT(4) and 5-HT(6) receptors in learning and memory. Trends Pharmacol. Sci. 2008.
137. Kitson S.L. 5-Hydroxytryptamine (5-HT) receptor ligands. Curr. Pharm. Des. 2007, 13:2621-2637.
138. Klein M.T., Teitler M. Guinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug development. J. Neurochem. 2009, 109:268-274.
139. 3 receptor antagonist, reduces voluntary ethanol consumption in rats. Pharmacol. Biochem. Behav. 1992, 41:847-850.
140. Kranz G.S., Kasper S., Lanzenberger R. Reward and the serotonergic system. Neuroscience 2010, 166:1023-1035.
141. Kulkarni S.K., Dhir A. Current investigational drugs for major depression. Expert Opin. Invest. Drugs 2009, 18:767-788.
142. Kursar J.D., Nelson D.L., Wainscott D.B., Baez M. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor. Mol. Pharmacol. 1994, 46:227-234.
143. Lacosta S., Roberts D.C. MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 1993, 44:161-165.
144. Lane J.D., Pickering C.L., Hooper M.L., Fagan K., Tyers M.B., Emmett-Oglesby M.W. Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug Alcohol Depend. 1992, 30:151-162.
145. Lanzenberger R.R., Mitterhauser M., Spindelegger C., Wadsak W., Klein N., Mien L.K., Holik A., Attarbaschi T., Mossaheb N., Sacher J., Geiss-Granadia T., Kletter K., Kasper S., Tauscher J. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol. Psychiatry 2007, 61:1081-1089.
146. Lappalainen J., Long J.C., Eggert M., Ozaki N., Robin R.W., Brown G.L., Naukkarinen H., Virkkunen M., Linnoila M., Goldman D. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry 1998, 55:989-994.
147. 2B receptor signaling in serotonergic neuronal cells. FASEB J. 2006, 20:1843-1854.
148. Lechin F., van der Dijs B., Hernandez-Adrian G. Dorsal raphe vs. median raphe serotonergic antagonism anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog. Neuro-psychopharmacol. Biol. Psychiatry 2006, 30:565-585.
149. Leggio G.M., Cathala A., Neny M., Rouge-Pont F., Drago F., Piazza P.V., Spampinato U. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J. Neurochem. 2009, 111:614-623.
150. 2B receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berl.) 2008, 201:443-458.
151. Lieberman J.A., Mailman R.B., Duncan G., Sikich L., Chakos M., Nichols D.E., Kraus J.E. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol. Psychiatry 1998, 44:1099-1117.
152. Liechti M.E., Saur M.R., Gamma A., Hell D., Vollenweider F.X. Psychological and physiological effects of MDMA (" Ecstasy" ) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 2000, 23:396-404.
153. Lovinger D.M., White G. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol. Pharmacol. 1991, 40:263-270.
154. Lowry C.A., Lightman S.L., Nutt D.J. That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion. J. Psychopharmacol. 2009, 23:392-400.
155. 1F receptor II. Autoradiographic localization in rat, guinea pig, monkey and human brain. Naunyn Schmiedebergs Arch. Pharmacol. 2005, 371:178-184.
156. Lyness W.H., Friedle N.M., Moore K.E. Increased self-administration of d-amphetamine after destruction of 5-hydroxytryptaminergic neurons. Pharmacol. Biochem. Behav. 1980, 12:937-941.
157. Mannoury la Cour C., El Mestikawy S., Hanoun N., Hamon M., Lanfumey L. Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain. Mol. Pharmacol. 2006, 70:1013-1021.
158. Markou A., Harrison A.A., Chevrette J., Hoyer D. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats. Psychopharmacology (Berl.) 2005, 178:133-142.
159. Maurel S., De Vry J., Schreiber R. 5-HT receptor ligands differentially affect operant oral self-administration of ethanol in the rat. Eur. J. Pharmacol. 1999, 370:217-223.
160. McBride W.J., Chernet E., Russell R.N., Wong D.T., Guan X.M., Lumeng L., Li T.K. Regional CNS densities of monoamine receptors in alcohol-naive alcohol-preferring P and -nonpreferring NP rats. Alcohol 1997, 14:141-148.
161. McBride W.J., Murphy J.M., Gatto G.J., Levy A.D., Yoshimoto K., Lumeng L., Li T.K. CNS mechanisms of alcohol self-administration. Alcohol Alcohol Suppl. 1993, 2:463-467.
162. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav. Brain Res. 1999, 101:129-152.
163. McCabe C., Mishor Z., Cowen P.J., Harmer C.J. Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment. Biol. Psychiatry 2010, 67:439-445.
164. McKinzie D.L., McBride W.J., Murphy J.M., Lumeng L., Li T.K. Effects of MDL 72222, a serotonin3 antagonist, on operant responding for ethanol by alcohol-preferring P rats. Alcohol Clin. Exp. Res. 2000, 24:1500-1504.
165. Meert T.F. Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol Alcohol 1993, 28:157-170.
166. Meltzer H.Y., Sumiyoshi T. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?. Behav. Brain Res. 2008, 195:98-102.
167. Miliaressis E., Rompre P.P., Laviolette P., Philippe L., Coulombe D. The curve-shift paradigm in self-stimulation. Physiol. Behav. 1986, 37:85-91.
168. Millan M.J. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics 2009, 6:53-77.
169. 4 ligands: an update of medicinal chemistry research in the last few years. Curr. Med. Chem. 2010, 17:334-362.
170. 1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward. J. Neural Transm. Gen. Sect. 1991, 83:139-148.
171. 3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission. J. Neural Transm. Gen. Sect. 1993, 91:1-11.
172. 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur. Neuropsychopharmacol. 1996, 6:169-175.
173. 2A antagonist. Behav. Brain Res. 1996, 73:163-167.
174. 2C receptor ligands on place conditioning and locomotor activity in rats. Eur. J. Pharmacol. 2005, 515:107-116.
175. 2C receptor agonist WAY 161503 in rats. Neuropharmacology 2006, 51:641-650.
176. 1A-receptors. Prog. Neurobiol. 2007, 81:133-178.
177. Nader M.A., Woolverton W.L. Cocaine vs. food choice in rhesus monkeys: effects of increasing the response cost for cocaine. NIDA Res. Monogr. 1990, 105:621.
178. Navailles S., Moison D., Cunningham K.A., Spampinato U. Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 2008, 33:237-246.
179. Neisewander J.L., McDougall S.A., Bowling S.L., Bardo M.T. Conditioned taste aversion and place preference with buspirone and gepirone. Psychopharmacology (Berl.) 1990, 100:485-490.
180. 5 receptors. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:53-58.
181. 1B receptors in nucleus accumbens efferents sensitizes animals to cocaine. J. Neurosci. 2002, 22:10856-10863.
182. Ogren S.O., Eriksson T.M., Elvander-Tottie E., D'Addario C., Ekstrom J.C., Svenningsson P., Meister B., Kehr J., Stiedl O. The role of 5-HT(1A) receptors in learning and memory. Behav. Brain Res. 2008, 195:54-77.
183. Olds J., Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 1954, 47:419-427.
184. Olds J., Yuwiler A., Olds M.E., Yun C. Neurohumors in hypothalamic substrates of reward. Am. J. Physiol. 1964, 207:242-254.
185. 2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. Int. J. Neuropsychopharmacol. 2010, 1-14.
186. Papp M., Willner P. 8-OH-DPAT-induced place preference and place aversion: effects of PCPA and dopamine antagonists. Psychopharmacology (Berl.) 1991, 103:99-102.
187. Parsons L.H., Weiss F., Koob G.F. Serotonin1B receptor stimulation enhances cocaine reinforcement. J. Neurosci. 1998, 18:10078-10089.
188. Patel S., Roberts J., Moorman J., Reavill C. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain. Neuroscience 1995, 69:1159-1167.
189. Pauwels P.J., Tardif S., Palmier C., Wurch T., Colpaert F.C. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines. Neuropharmacology 1997, 36:499-512.
190. Pedigo N.W., Yamamura H.I., Nelson D.L. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J. Neurochem. 1981, 36:220-226.
191. 3 antagonist, fails to alter cocaine self-administration in rats. Pharmacol. Biochem. Behav. 1991, 39:133-136.
192. Peltier R., Schenk S. Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology (Berl.) 1993, 110:390-394.
193. Pentkowski N.S., Acosta J.I., Browning J.R., Hamilton E.C., Neisewander J.L. Stimulation of 5-HT(1B) receptors enhances cocaine reinforcement yet reduces cocaine-seeking behavior. Addict. Biol. 2009, 14:419-430.
194. Peroutka S.J., Snyder S.H. [3H]Mianser differential labeling of serotonin histamine receptors in rat brain. J. Pharmacol. Exp. Ther. 1981, 216:142-148.
195. Pessia M., Jiang Z.G., North R.A., Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 1994, 654:324-330.
196. Pfaus J.G. Pathways of sexual desire. J. Sex. Med. 2009, 6:1506-1533.
197. Poschel B.P., Ninteman F.W., McLean J.R., Potoczak D. Intracranial reward after 5,6-dihydroxytryptamine: further evidence for serotonin's inhibitory role. Life Sci. 1974, 15:1515-1522.
198. 1B receptor ligands on the cocaine- and food-maintained self-administration in rats. Eur. J. Pharmacol. 2007, 559:165-172.
199. Ranck J.B. Which elements are excited in electrical stimulation of mammalian central nervous system: a review. Brain Res. 1975, 98:417-440.
200. 7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. Naunyn Schmiedebergs Arch. Pharmacol. 2007, 376:93-105.
201. Rauser L., Savage J.E., Meltzer H.Y., Roth B.L. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor. J. Pharmacol. Exp. Ther. 2001, 299:83-89.
202. 4 receptor antagonism does not affect motor and reward mechanisms in the rat. Eur. J. Pharmacol. 1998, 357:115-120.
203. Redgrave P., Horrell R.I. Potentiation of central reward by localised perfusion of acetylcholine and 5-hydroxytryptamine. Nature 1976, 262:305-307.
204. 2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:1021-1028.
205. 1A receptor blockade and the motivational profile of ethanol. Life Sci. 2002, 71:707-715.
206. 1b knockout mice. Behav. Brain Res. 1999, 102:211-215.
207. Risinger F.O., Oakes R.A. Mianserin enhancement of ethanol-induced conditioned place preference. Behav. Pharmacol. 1996, 7:294-298.
208. Roberts A.J., McArthur R.A., Hull E.E., Post C., Koob G.F. Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol. Psychopharmacology (Berl.) 1998, 137:25-32.
209. Rocha B., Di Scala G., Jenck F., Moreau J.L., Sandner G. Conditioned place aversion induced by 5-HT(1C) receptor antagonists. Behav. Pharmacol. 1993, 4:101-106.
210. 1B receptors. Pharmacol. Biochem. Behav. 1997, 57:407-412.
211. Rocha B.A., Goulding E.H., O'Dell L.E., Mead A.N., Coufal N.G., Parsons L.H., Tecott L.H. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J. Neurosci. 2002, 22:10039-10045.
212. Rocha B.A., Scearce-Levie K., Lucas J.J., Hiroi N., Castanon N., Crabbe J.C., Nestler E.J., Hen R. Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature 1998, 393:175-178.
213. Rodd-Henricks Z.A., McKinzie D.L., Melendez R.I., Berry N., Murphy J.M., McBride W.J. Effects of serotonin-3 receptor antagonists on the intracranial self-administration of ethanol within the ventral tegmental area of Wistar rats. Psychopharmacology (Berl.) 2003, 165:252-259.
214. Rodd Z.A., Bell R.L., Kuc K.A., Zhang Y., Murphy J.M., McBride W.J. Intracranial self-administration of cocaine within the posterior ventral tegmental area of Wistar rats: evidence for involvement of serotonin-3 receptors and dopamine neurons. J. Pharmacol. Exp. Ther. 2005, 313:134-145.
215. Rodd Z.A., Bell R.L., Oster S.M., Toalston J.E., Pommer T.J., McBride W.J., Murphy J.M. Serotonin-3 receptors in the posterior ventral tegmental area regulate ethanol self-administration of alcohol-preferring (P) rats. Alcohol 2010, 44:245-255.
216. Rodd Z.A., Bell R.L., Zhang Y., Murphy J.M., Goldstein A., Zaffaroni A., Li T.K., McBride W.J. Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology 2005, 30:330-338.
217. Rodd Z.A., Gryszowka V.E., Toalston J.E., Oster S.M., Ji D., Bell R.L., McBride W.J. The reinforcing actions of a serotonin-3 receptor agonist within the ventral tegmental area: evidence for subregional and genetic differences and involvement of dopamine neurons. J. Pharmacol. Exp. Ther. 2007, 321:1003-1012.
218. 3 receptor antagonist, on morphine-induced potentiation of brain stimulation reward. Eur. J. Pharmacol. 1995, 287:263-269.
219. Rothman R.B., Blough B.E., Baumann M.H. Dopamine/serotonin releasers as medications for stimulant addictions. Prog. Brain Res. 2008, 172:385-406.
220. Ruf B.M., Bhagwagar Z. The 5-HT(1B) receptor: a novel target for the pathophysiology of depression. Curr. Drug Targets 2009.
221. Salamone J.D. Will the last person who uses the term'reward' please turn out the lights? Comments on processes related to reinforcement, learning, motivation and effort. Addict. Biol. 2006, 11:43-44.
222. Salamone J.D., Correa M., Mingote S.M., Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 2005, 5:34-41.
223. Sanchis-Segura C., Spanagel R. Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict. Biol. 2006, 11:2-38.
224. Sari Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 2004, 28:565-582.
225. Sari Y., Miquel M.C., Brisorgueil M.J., Ruiz G., Doucet E., Hamon M., Verge D. Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 1999, 88:899-915.
226. Schenk S. Effects of the serotonin 5-HT(2) antagonist, ritanserin, and the serotonin 5-HT(1A) antagonist, WAY 100635, on cocaine-seeking in rats. Pharmacol. Biochem. Behav. 2000, 67:363-369.
227. Schipper J., Tulp M.T., Sijbesma H. Neurochemical profile of eltoprazine. Drug Metabol. Drug Interact. 1990, 8:85-114.
228. 1A receptor agonist ipsapirone on operant self-administration of ethanol in the rat. Eur. Neuropsychopharmacol. 1999, 10:37-42.
229. Schultz W. Behavioral theories and the neurophysiology of reward. Annu. Rev. Psychol. 2006, 57:87-115.
230. 2C receptors in GABAergic cells of the anterior raphe nuclei. J. Chem. Neuroanat. 2005, 29:83-91.
231. Shippenberg T., Koob G. Chap. 97, recent advances in animal models of drug addiction. Neuropsychopharmacology: The Fifth Generation of Progress 2002, 1381-1398. American College of Neuropsychopharmacology. 5th edition. K.L.C.D. Davis, J.T. Coyle, C. Nemeroff (Eds.).
232. Shippenberg T.S. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetral involvement of 5-hydroxytryptamine 1A D1 dopamine F receptors. Neurosci. Lett. 1991, 121:136-138.
233. Silvestre J.S., Palacios J.M., Fernandez A.G., O'Neill M.F. Comparison of effects of a range of 5-HT receptor modulators on consumption and preference for a sweetened ethanol solution in rats. J. Psychopharmacol. 1998, 12:168-176.
234. Stellar J.R., Rice M.B. Pharmacological basis of intracranial self-stimulation reward. The Neuropharmacological Basis of Reward 1989, 14-65. Oxford Science Publications. J.M. Liebman, S.J. Cooper (Eds.).
235. Subhan F., Deslandes P.N., Pache D.M., Sewell R.D. Do antidepressants affect motivation in conditioned place preference?. Eur. J. Pharmacol. 2000, 408:257-263.
236. 7 antagonists with potential as antischizophrenic drugs: serominic compounds. Bioorg. Med. Chem. Lett. 2007, 17:2649-2655.
237. Suzuki T., Aoki T., Kato H., Yamazaki M., Misawa M. Effects of the 5-HT(3) receptor antagonist ondansetron on the ketamine- and dizocilpine-induced place preferences in mice. Eur. J. Pharmacol. 1999, 385:99-102.
238. 3 receptor antagonists block cocaine- and methamphetamine-induced place preference. Yakubutsu Seishin Kodo 1992, 12:33-38.
239. Thomas D.R. 5-ht5A receptors as a therapeutic target. Pharmacol. Ther. 2006, 111:707-714.
240. 3 receptor as a therapeutic target. Expert Opin. Therap. Targets 2007, 11:527-540.
241. Tomkins D.M., Joharchi N., Tampakeras M., Martin J.R., Wichmann J., Higgins G.A. An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour. Pharmacol. Biochem. Behav. 2002, 71:735-744.
242. Tomkins D.M., O'Neill M.F. Effect of 5-HT(1B) receptor ligands on self-administration of ethanol in an operant procedure in rats. Pharmacol. Biochem. Behav. 2000, 66:129-136.
243. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am. J. Psychiatry 2006, 163:28-40.
244. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 2007, 12:227-462.
245. Van Der Kooy D., Fibiger H.C., Phillips A.G. An analysis of dorsal and median raphe self-stimulation: effects of parachlorophenylalanine. Pharmacol. Biochem. Behav. 1978, 8:441-445.
246. van Wijngaarden I., Tulp M.T., Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 1990, 188:301-312.
247. 7 receptors: current knowledge and future prospects. Trends Pharmacol. Sci. 2000, 21:70-77.
248. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Babler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 1998, 9:3897-3902.
249. Ward R.P., Hamblin M.W., Lachowicz J.E., Hoffman B.J., Sibley D.R., Dorsa D.M. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 1995, 64:1105-1111.
250. Watson J.M., Dawson L.A. Characterization of the potent 5-HT(1A/B) receptor antagonist and serotonin reuptake inhibitor SB-649915: preclinical evidence for hastened onset of antidepressant/anxiolytic efficacy. CNS Drug Rev. 2007, 13:206-223.
251. Wesolowska A., Kowalska M. Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats. Pharmacol. Rep. 2008, 60:464-474.
252. 7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur. J. Pharmacol. 2006, 553:185-190.
253. Wesolowska A., Nikiforuk A., Stachowicz K., Tatarczynska E. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression. Neuropharmacology 2006, 51:578-586.
254. Wilson A.W., Costall B., Neill J.C. Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system. J Psychopharmacol 2000, 14:340-346.
255. 1A receptor agonist 8-OH-DPAT reduces ethanol intake and maintained behavior in female Sprague-Dawley rats. Alcohol 1996, 13:407-413.
256. Wilson A.W., Neill J.C., Costall B. An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat. Alcohol 1998, 16:249-270.
257. Winter J.C. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology (Berl) 2009, 203:251-263.
258. Wirtshafter D. The control of ingestive behavior by the median raphe nucleus. Appetite 2001, 36:99-105.
259. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 1996, 19:319-340.
260. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36:229-240.
261. Wise R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 2004, 5:483-494.
262. Yan Q.S., Yan S.E. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur. J. Pharmacol. 2001, 418:55-64.
263. Yan Q.S., Zheng S.Z., Yan S.E. Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Res. 2004, 1021:82-91.
264. Yocca F.D., Iben L., Meller E. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Mol. Pharmacol. 1992, 41:1066-1072.
265. Yu D.S., Smith F.L., Smith D.G., Lyness W.H. Fluoxetine-induced attenuation of amphetamine self-administration in rats. Life Sci. 1986, 39:1383-1388.
266. Zhou F.C., McKinzie D.L., Patel T.D., Lumeng L., Li T.K. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats. Alcohol Clin. Exp. Res. 1998, 22:266-269.
267. Ziauddeen H., Murray G.K. The relevance of reward pathways for schizophrenia. Curr. Opin. Psychiatry 2010, 23:91-96.